Novartis India

34
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
786.80
-10.3 (-1.29%)
BSENSE

Dec 05

BSE+NSE Vol: 23.75 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024

Compare Profit and Loss Results of Novartis India
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
1,283.00
-927.00
-72.25%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
356.00
1,283.00
-927.00
-72.25%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
39.00
-36.00
-92.31%
Raw Materials Consumed
199.00
587.00
-388.00
-66.10%
Power & Fuel Cost
0.00
94.00
-94.00
-100.00%
Employee Cost
18.00
211.00
-193.00
-91.47%
Operating Expenses
8.00
67.00
-59.00
-88.06%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
24.00
-14.00
-58.33%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
9.00
20.00
-11.00
-55.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
264.00
1,079.00
-815.00
-75.53%
Operating Profit (PBDIT) excl Other Income
91.00
203.00
-112.00
-55.17%
Other Income
41.00
9.00
32.00
355.56%
Operating Profit (PBDIT)
133.00
212.00
-79.00
-37.26%
Interest
0.00
114.00
-114.00
-100.00%
Profit before Depriciation and Tax
132.00
98.00
34.00
34.69%
Depreciation
2.00
99.00
-97.00
-97.98%
Profit Before Taxation & Exceptional Items
130.00
-1.00
131.00
13,100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
130.00
-1.00
131.00
13,100.00%
Provision for Tax
29.00
0.00
29.00
0%
Profit After Tax
100.00
-1.00
101.00
10,100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
728.00
-316.00
1,044.00
330.38%
Profit Available for appropriations
829.00
-317.00
1,146.00
361.51%
Appropriations
829.00
-317.00
1,146.00
361.51%
Equity Dividend (%)
500%
0%
500.00
Earnings Per Share
40.87
-0.27
41.14
15,237.04%
Profit And Loss - Net Sales
Net Sales 356.27 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.33% vs -11.53% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.42 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 40.09% vs 0.28% in Mar 2024

Profit And Loss - Interest
Interest 0.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -48.32% vs -14.86% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 100.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.44% vs -17.58% in Mar 2024